Chlorzoxazone,tolbutamide and midazolam,the probe drugs of three cytochrome P450,can be determined in plasma of rats by HPLC in a single run
Zhu Dong-chu
Abstract
Zhu Dong-chu
Abstract
Objective To establish an efficient,rapid,selective HPLC method for determining three CYP450 s probe drugs,chlorzoxazone,tolbutamide and midazolam,in single run in rat plasma. Methods The three specific probe substrates of chlorzoxazone,tolbutamide,and midazolam,together with the internal standard diazepam,could be extracted using liquid-liquid extraction in rat plasma,followed by high-performance liquid chromatography( HPLC) using a C18column( 250 mm × 4. 6 mm,5 μm). The mobile phase was constituted of a methanol and 0. 05 mol·L- 1phosphate buffer( 61 ∶ 39,V / V). Results All analytes were separated simultaneously in a single run. The detection limits ranged from 0. 1 ~ 50 mg·L- 1for chlorzoxazone,tolbutamide and midazolam. The precisions for three probe substrates were 4. 78% ~ 9. 78%,the accuracy of three probe substrates ranged from 92. 71% ~ 109. 79%. The limit of quantification( LOQ) was 0. 1 mg·L- 1for chlorzoxazone,tolbutamide and midazolam. Conclusions The present method provides a robust,fast analytical tool for the three-probe drug cocktail. Finally,the method was suitable for determining the plasma concentration of these compounds and evaluating the CYP2E1,CYP2C9 and CYP3A4 activities in the drug-drug interaction studies.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To establish an efficient,rapid,selective HPLC method for determining three CYP450 s probe drugs,chlorzoxazone,tolbutamide and midazolam,in single run in rat plasma. Methods The three specific probe substrates of chlorzoxazone,tolbutamide,and midazolam,together with the internal standard diazepam,could be extracted using liquid-liquid extraction in rat plasma,followed by high-performance liquid chromatography( HPLC) using a C18column( 250 mm × 4. 6 mm,5 μm). The mobile phase was constituted of a methanol and 0. 05 mol·L- 1phosphate buffer( 61 ∶ 39,V / V). Results All analytes were separated simultaneously in a single run. The detection limits ranged from 0. 1 ~ 50 mg·L- 1for chlorzoxazone,tolbutamide and midazolam. The precisions for three probe substrates were 4. 78% ~ 9. 78%,the accuracy of three probe substrates ranged from 92. 71% ~ 109. 79%. The limit of quantification( LOQ) was 0. 1 mg·L- 1for chlorzoxazone,tolbutamide and midazolam. Conclusions The present method provides a robust,fast analytical tool for the three-probe drug cocktail. Finally,the method was suitable for determining the plasma concentration of these compounds and evaluating the CYP2E1,CYP2C9 and CYP3A4 activities in the drug-drug interaction studies.
Key concepts: Chlorzoxazone, Tolbutamide, Chromatography, Chemistry, Midazolam, High-performance liquid chromatography, Detection limit, Analyte